Akoya Biosciences Sees FY24 Revenue $114M-$118M Vs $117.38M Est.
Portfolio Pulse from Benzinga Newsdesk
Akoya Biosciences projects its full year 2024 revenue to be in the range of $114M-$118M, which is around the analyst estimate of $117.38M. The company also aims to achieve operating cash flow breakeven by the end of 2024.
March 04, 2024 | 9:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akoya Biosciences expects FY24 revenue to be $114M-$118M, close to the $117.38M estimate, and aims for cash flow breakeven by year-end.
The revenue forecast by Akoya Biosciences is closely aligned with analyst expectations, indicating a positive outlook for the company. Achieving operating cash flow breakeven by the end of 2024 would be a significant milestone, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100